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Abstract
Background. Increased intra-abdominal pressure (IAP) is detrimental for the recovery of organ function in trauma and
emergency patients. The aim of this study was to assess the correlation between the dynamics of IAP and organ dysfunction
in severe acute pancreatitis (SAP). Materials and methods. Management of SAP between 2000 and 2004 was analysed. SAP
was classified according to Atlanta 1992. Organ dysfunction, systemic inflammatory response syndrome (SIRS) and
outcomes in relation to the IAP were assessed. IAP was measured indirectly. Results. A total of 65 patients, with an average
APACHE II score of 6.44, complied with the Atlanta criteria. In all, 34 patients received conservative treatment and 31 were
operated. SIRS was observed in 59 cases and multiple organ dysfunction syndrome (MODS) in 61 cases. IAP was
significantly higher in the 25 most complicated patients requiring renal replacement therapy (RRT), compared with
40 patients without RRT, 31.72 vs 21.4 cm/H2O (p/0.037). IAP interrelated positively with SOFA score (r//0.371,
pB/0.01) and organs involved (r//0.356, pB/0.01), and negatively with platelet count and enterally provided volume
(r//0.284, pB/0.01; r//0.5, pB/0.01, respectively). Overall mortality (9.2%) was associated with surgery and
sustained increase of the IAP over 25 cm/H2O. Our data support the pathophysiological interrelation of elevated IAP and
development of organ dysfunction. Conclusion. Development of organ dysfunction in SAP could be associated with
increased IAP. Grade III increase of IAP should be considered as an indicator for revision of treatment modalities.
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Introduction
Despite recent evidence-based experience in the
management of severe acute pancreatitis (SAP) it is
too early to say that this disease could be taken under
control. The mortality rate is considerably high even
in the centres of excellence, reaching up to 1525%
[13]. Early risk factor assessment is one of the main
determinants for the appropriate management of the
disease. Different severity assessment scoring systems
and single parameters have been introduced for this
purpose such as the APACHE II score, Ranson
criteria, Imrie score, Balthasar score, and others
[4,5]. Clinical utility of these systems is mainly of
prognostic value and gives us the possibility of
following a certain treatment strategy. However, a
more dynamic assessment of the early signs of
deterioration of the clinical course is crucial for
further improvement of treatment results in the
most severe category of patients. One of the main
dynamic pathophysiological events in the early course
of SAP is systemic inflammatory response syndrome
(SIRS) as a result of proinflammatory cytokine
effects, with the characteristic changes in vascular
permeability [6]. However, diagnostic efficacy of the
cytokine detection is not clinically approved [7]. A
more practical approach could be assessment of the
initial signs of organ dysfunction according to MODS
(multiple organ dysfunction syndrome) or SOFA
score. These scores are mainly applicable in an
intensive care unit (ICU) setting because of the
necessity of multi-parameter data collection. At the
same time, markedly increased intra-abdominal pres-
sure (IAP) is recognized as a detrimental factor for the
recovery of organ function in trauma and abdominal
emergency patients [8]. Negative physiological sequel
of markedly increased IAP is recognized as a crucial
factor in the development of MODS; however, it is
mainly mentioned in association with trauma patients.
Measurement of the IAP is reported as a clinical
routine for detection of acute abdominal compart-
ment syndrome and recognition of those patients for
whom emergency laparotomy is indicated when con-
servative ICU treatment fails to reduce IAP [9].
Although it is noted that acute pancreatitis is a disease
commonly associated with increased IAP, no data are
available regarding the clinical utility of the routine
measurement of IAP in patients with SAP. The aim of
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this study was to assess whether increased IAP affects
the clinical course and reflects on the effectiveness of
conservative treatment, as well as to investigate the
correlation between the degree of organ dysfunction
and dynamics of IAP in patients suffering SAP.
Materials and methods
Our experience in the management of SAP between
the years 2000 and 2004 was analysed retrospectively.
SAP was classified according to Atlanta 1992 [10]. All
patients were treated in an ICU. The dynamics of
organ dysfunction, clinical course of SIRS, main
physiological parameters and outcomes in relation to
the IAP were assessed. IAP measurement was
done indirectly through the urinary bladder [11].
Only patients with repeated IAP measurements were
included.
Diagnosis of SAP was supported by evidence of
severe clinical presentation of the disease, threefold
increase of the lipase activity in blood and one of the
following criteria: SIRS and/or signs of organ dys-
function, APACHE II score ]/6. Necrotizing pan-
creatitis was diagnosed when ultrasound and CT scan
or intraoperative findings demonstrated evidence of
necrotic areas in the pancreatic gland or peripancrea-
tic area; CRP was ]/150 mg/L.
Organ failure was defined according to the recom-
mendations of the Consensus Conference of the
American College of Chest Physicians/Society of
Critical Care Medicine in 1991 [12,13]. Accordingly,
SIRS was diagnosed if two or more of the following
conditions were detected: (a) temperature above 388C
or below 368C, (b) heart rate above 90 beats/min,
(c) respiratory rate above 20 breaths/min or arterial
carbon dioxide tension below 32 mmHg, and
(d) white blood cell count above 12 000/mm3 or
below 4000/mm3, or immature (band) forms account-
ing for more than 10% of neutrophils present [14]. A
MODS was diagnosed if dysfunction of more than
one organ was detected, requiring intervention to
maintain homeostasis. SOFA score was calculated for
daily assessment of the dynamics of organ dysfunc-
tion. Radiological evidence of basal atelectasis, pneu-
monia or pleural effusion was recorded separately
from the pulmonary dysfunction assessed by SOFA
score and classified as pulmonary complications.
Acidosis was diagnosed when the pH in the peripheral
blood was B/7.2. All patients were retrospectively
stratified in two groups for better assessment of the
physiological role of increased IAP on the clinical
course of the disease. The landmark for stratification
was IAP]/25 cm/H2O, correspondent value of the
abdominal compartment grade IIIIV.
Hospital and ICU stay, complication rate and main
outcomes were analysed. Statistical comparison was
done with paired samples t test. All clinical data
were expressed as average9/standard deviation (SD).
Correlation data were calculated using Pearson’s and
Spearman’s correlation test. The data analysis
was performed with SPSS software version 8.0
(SPSS Inc.).
Results
In total 65 patients with average age of 47.879/14.43
matched the inclusion criteria. Of these patients, 45
were male and 20 were female patients, admitted on
average 2.3 days from the onset of the disease.
APACHE II score was 6.449/4.7 on admission for
the whole group. All patients received initial conser-
vative treatments including organ support, active
recovery of the tissue perfusion and reduction of the
fluid sequestration in the third space by means of
isovolaemic haemodilution with adequate colloid/
crystalloid infusions. The main indications for the
application of the renal replacement therapy were
deterioration of the clinical course mainly due to
progression of organ dysfunction and critical increase
of the IAP after the initial 2448 hours of therapy.
Blood purification therapy included haemodialysis
and/or continuous veno-venous haemofiltration
(CVVH). Conservative treatment alone was success-
ful in 34 patients. The main indication for surgical
intervention was infection. Progressive deterioration
of the clinical course despite initial conservative
treatment or obscure diagnosis at admission, in
some cases, was the specific indication for surgery.
Laparotomies with sequestrectomy, mobilization of
the peripancreatic region including liver and splenic
flexure of the colon and insertion of the lavage system
usually were performed. Abdominal closure in the
majority of cases was semi-open. Additional surgical
interventions were needed in 31 cases.
The clinical course was complicated by develop-
ment of SIRS in 59 patients and development of
MODS in 61 patients. Increase of the IAP below the
level of 25 cm/H2O reaching on average 17.249/
3.94 cm/H2O complicated the clinical course in 41
cases. However, in 24 patients, IAP exceeded 25 cm/
H2O, reaching 39.259/14.67 cm/H2O for this group.
Comparison with the t test did not reveal any
significant difference in the results of the incidence
of the organ dysfunction according to SOFA score
calculation when comparing patients who did not
reach elevation of the IAP up to 25 cm/H2O and those
who did reach /25 cm/H2O, except in the higher rate
of pulmonary dysfunction in the more hypertensive
group. At the same time, there were six lethal
outcomes associated with abdominal compartment
grade IIIIV compared with zero deaths in those who
did not reach elevation of the IAP up to 25 cm/H2O,
p/0.011 (Table I).
The profile of the IAP was significantly higher
in the 25 most complicated patients who required
renal replacement therapy (RRT), compared with
40 patients who were managed without RRT, 31.72
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(1270) vs 21.4 (1078) cm/H2O, p/0.037, respec-
tively (Figure 1).
Correlation test for all available measurements of
the IAP and corresponding values of the SOFA score
demonstrated positive interrelation, r//0.371, pB/
0.01 (Figure 2). The same tendency was noted with
IAP and the number of organs involved, r//0.356,
pB/0.01. Again, the frequency of cases of liver, renal
and pulmonary dysfunction positively correlated with
IAP, accordingly r//0.305, pB/0.01; r//0.167,
pB/0.01; r//0.153, pB/0.05, respectively. Negative
interrelation was observed with platelet count and
enterally provided volume, r/0.284, pB/0.01;
r//0.5, pB/0.01, respectively.
There was no statistical difference when comparing
the degree of the IAP among operated and conserva-
tively treated patients (Table II, Figure 3) and,
according to medical records, elevation of the IAP
was not considered to be the single indication for
surgery. In contrast, we observed a significantly higher
incidence of organ dysfunction and complication rate
in patients who underwent surgical intervention
compared with conservatively treated patients. Pre-
dominant incidence of pulmonary complications and
pulmonary dysfunction was evidently associated with
renal dysfunction and development of abdominal
compartment grade IIIIV either before or after
surgical intervention (Table III). The average time
for surgical intervention in our series was 6.879/10.48
days after admission. Unfortunately the average tim-
ing of surgical intervention was affected by a certain
number of patients who were operated early in the
course of SAP. Generally we have followed the
strategy of postponing surgical intervention as much
as possible after the third week. However in some
cases other colleagues ignored this strategy. It is
noteworthy that the dynamics of the IAP were not
considerably affected by surgical intervention and that
most complications developed after surgical interven-
tion (Table IV). Significantly longer ICU stay and
hospital stay in operated patients partially reflected
advantages of conservative strategy and disadvantages
of early surgical intervention.
The overall mortality rate in the analysed group of
patients reached 9.2% (six cases). All lethal outcomes
were associated with sustained increase of the IAP
over 25 cm/H2O (an average 40.179/16.5 cm/H2O)
corresponding to abdominal compartment grade
IIIIV and early surgical intervention. The clinical
Table I. Development of SIRS, MODS, complication rate and
mortality in patients with IAPB/25 cm/H2O and /25 cm/H2O.
Parameter
IAPB/25 cm/H2O
(n/41)
IAP/25 cm/H2O
(n/24) p value
SIRS 36 23 NS
MODS 38 23 NS
Renal dysfunction 10 12 NS
Encephalopathy 2 5 NS
Haematologic
dysfunction
20 17 NS
Pulmonary
dysfunction
13 14 0.008
Atelectasis 1 5 NS
Pneumonia 4 7 NS
Pleural effusion 13 9 NS
Metabolic acidosis 2 5 NS
Exitus 0 6 0.011
IAP, intra-abdominal pressure; MODS, multiple organ dysfunction
syndrome; SIRS, systemic inflammatory response syndrome.
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Figure 1. Profile of the intra-abdominal pressure (IAP) in patients
who were treated with or without renal replacement therapy (RRT).
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Figure 2. Positive interrelation with intra-abdominal pressure (IAP)
and SOFA score.
Table II. Clinical course in operated/non-operated patients.
Parameter Operated Not operated p value
Number 31 34 
Mean IAP (cm/H2O) 27.67 23.26 NS
APACHE II (points) 7.16 5.79 NS
SIRS (no. of cases) 29 30 NS
MODS (no. of cases) 29 32 NS
Hospital stay (days) 45.32 18.23 B/0.05
ICU stay (days) 16.6 7.9 0.01
IAP, intra-abdominal pressure; ICU, intensive care unit; MODS,
multiple organ dysfunction syndrome; SIRS, systemic inflammatory
response syndrome.
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course of patients with lethal outcomes was associated
with a high incidence of postoperative complications
(Table V).
Discussion
Negative clinical consequences of the sustained
increase of the IAP are well established mainly in
trauma patients, and a certain degree of the abdom-
inal compartment is considered a strong indication for
abdominal exploration [15,16]. However, the real
pathophysiological role of the abdominal compart-
ment syndrome, which can develop due to marked
increase of the IAP in patients with SAP, is not clearly
defined. Our retrospective study aimed to clarify
whether there is a correlation between elevation of
the IAP, the clinical course of the disease and the
mode of treatment in this category of patients. The
possibility of such an important clinical physiological
connection was based on evidence that disturbances
of the microcirculation and insufficient perfusion/
oxygenation of the end organ is claimed to be the
central pathophysiological event in the sepsis-like
systemic inflammatory response as a result of the
interplay of the numerous cytokines [17]. The clinical
and pathophysiological manifestation of the systemic
inflammatory response and end organ dysfunction are
similar in the clinical course of SAP and sepsis
[18,19]. Increased permeability of the capillary net-
work and accumulation of fluid in the extravascular
compartment are among the most characteristic
features of the excessive excretion of pro- and
anti-inflammatory cytokines [17]. Sequestration of
the enzymatically rich fluid in the retroperitoneal
space and/or intraperitoneally, accompanied by visc-
eral oedema, is typical in SAP due to the above-
mentioned cytokine effects. This mechanism is
involved in the development of the abdominal com-
partment syndrome. Sustained increase of the IAP
affects most intra-abdominal organs, and negative
consequences of the intra-abdominal hypertension
can be observed when IAP goes beyond 15 cm/H2O.
Microcirculation of the gastrointestinal tract can be
affected severely when IAP reaches ]/25 cm H2O [8].
Our results demonstrate strong association between
sustained increase of the IAP and deterioration of the
clinical course in patients with SAP. Elevation of the
IAP was related to progression of organ dysfunction,
especially when the abdominal compartment reached
grade IIIIV. It is not surprising that pulmonary and
renal functions were affected most severely. Another
negative consequence was observed when commen-
cing enteral nutrition  tolerance of the enterally
provided formula was poor in such cases. AlthoughTable III. Complication rates* in operated/non-operated patient
groups.
Complication
Operated
(n/31)
Not operated
(n/34) p value
Renal dysfunction
(no. of cases)
16 6 0.003
Encephalopathy 6 1 NS
Haematological dysfunction 16 21 NS
Pulmonary dysfunction
(no. of cases)
16 11 0.05
Atelectasis (no. of cases) 6 0 0.012
Pneumonia (no. of cases) 8 3 0.031
Pleural effusion (no. of cases) 12 10 NS
Metabolic acidosis
(no. of cases)
7 0 0.006
Exitus (no. of cases) 6 0 0.012
*Rate of complications during the whole treatment period.
Table IV. Average time for the development of the complications in
operated patients.
Intervention/complications Days from admission
Surgical intervention 6.87
Renal dysfunction 5.92
Pulmonary dysfunction 11.63
Atelectasis 11.5
Pneumonia 17.25
Metabolic acidosis 13.14
Exitus 28.67
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Figure 3. Profile of the intra-abdominal pressure (IAP) in operated
and non-operated patients.
Table V. Average interval from admission until development of
complications and death.
Type of complications Number of cases* Days from admission
SIRS 5 4.5
MODS 6 2.5
Renal dysfunction 5 1
Pulmonary dysfunction 3 17
Atelectasis 3 1
Metabolic acidosis 4 1
Sepsis 1 26
Encephalopathy 3 20.67
Exitus 6 28.67
MODS, multiple organ dysfunction syndrome; SIRS, systemic
inflammatory response syndrome.
*Data reflect the clinical course of six patients who died.
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our study was not designed for particular assessment
of the enteral feeding in SAP patients, the available
data gave us a practical suggestion about impairment
of the bowel function and low tolerance of the
enterally provided feeding when IAP reaches nearly
20 cm/H2O. Taken together, our data support pre-
viously reported recommendations that well-designed
fluid replacement strategy based on adequate colloid/
crystalloid composition and organ support facilitates
reduction of the oedema and improves microcircula-
tion [20]. Reduction of the third space and elimina-
tion of cytokines could also be achieved by application
of RRT in the most severe cases [21]. Successful
complex conservative treatment can result in gradual
decrease of the IAP. According to our experience,
prevention of the increased IAP is a rather important
goal of the conservative treatment in patients with
SAP, and surgical treatment should be avoided if
possible. Surgical interventions, generally accepted
for the reduction of the abdominal compartment in
trauma patients, are difficult to apply directly to SAP
patients. Although there is some controversial experi-
ence with this, the results are not very encouraging
[22]. Our data are in parallel with the above-
mentioned findings. All lethal outcomes were asso-
ciated with sustained increase of the IAP over 25 cm/
H2O and early surgical intervention. At the same
time, dynamics of the IAP were not considerably
affected by surgical exploration of the abdominal
cavity, but most complications unfortunately occurred
after surgical intervention in our series.
Despite the well-established fact that infection of
necrosis is a major risk factor for the development of
MODS, there is a subgroup of patients with sterile
necrosis who develop progressive MODS. The new
term ‘early severe pancreatitis’ was used to describe
this category of patients [23,24]. Other triggering
factors rather than infection could be responsible for
the development of MODS in these cases. According
to our observation, overwhelming SIRS with devel-
opment of the abdominal compartment grade IIIIV
could be the pathophysiological link to the develop-
ment of MODS in early SAP. Therefore prevention of
the development of the abdominal compartment
syndrome could be rational from the strategic point
of view. Our data support the common opinion that
early recognition of SAP patients requiring pulmonary
and renal support is crucial and ICU management is
the best option for this category of patients. Timely
complex conservative strategy including control of the
IAP improves overall treatment results, and shortens
ICU and hospital stay.
Conclusion
Development of organ dysfunction in severe acute
pancreatitis could be associated with increased
IAP. Marked sustained grade III increase of IAP
should be considered as an indicator for revision of
the treatment modalities. Elevation of IAP over
25 cm/H2O should not be considered the single
indication for emergency decompressive laparotomy.
Aggressive conservative treatment including isovolae-
mic haemodilution and CVVH rather than surgical
intervention is recommended, particularly in the most
severe cases.
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